DUBLIN--(BUSINESS WIRE)--Nov 11, 2022--
The "Bioactive Peptide Market, by Source, by Therapeutic Area, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms. Many groups of bioactive peptides have been marketed chemically or recombinantly.
The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity, owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides are used as treatment therapy for most of the functional disorders such as irritable bowel disease, which is expected to drive the market growth.
Market Dynamics
Increasing research and development by key market players for the treatment of pulmonary edema and rheumatoid arthritis is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, on May 30, 2022, APEPTICO Forschung und Entwicklung GmbH, a biotechnology company, announced that the 3-D structure and the mechanism of action of Solnatide,( a dry powder inhalation and an inhaled aerosol formulation of a synthetic peptide) a possible treatment for pulmonary oedema, had been disclosed by an international network of scientists led by APEPTICO.
Key features of the study:
Detailed Segmentation:
Global Bioactive Peptide Market, By Source:
Global Bioactive Peptide Market, By Therapeutic Area:
Global Bioactive Peptide Market, By Distribution Channel:
Global Bioactive Peptide Market, By Region:
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Bioactive Peptide Market- Impact of Coronavirus (Covid-19) Pandemic
5. Global Bioactive Peptide Market, By Source, 2017 - 2030, (US$ Million)
6. Global Bioactive Peptide Market, By Therapeutic Area,2017 - 2030, (US$ Million)
7. Global Bioactive Peptide Market, By Distribution Channel, 2017 - 2030, (US$ Million)
8. Global Bioactive Peptide Market, By Region, 2017 - 2030, (US$ Million)
9. Competitive Landscape
10. Section
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/xcyj52
View source version on businesswire.com:https://www.businesswire.com/news/home/20221111005277/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/11/2022 08:14 AM/DISC: 11/11/2022 08:14 AM
http://www.businesswire.com/news/home/20221111005277/en